Received: 4 June 2017
Accepted: 18 June 2017
First Online: 30 August 2017
: C.G. is an employee of Relypsa Inc., a Vifor Pharma company. L.B.P. is an employee of Mallinckrodt Pharmaceuticals and owns stock in that company. The remaining authors declare no conflict of interest.
Free to read: This content has been made available to all.